Project Organization

The role of the consortium is to plan, oversee, and implement surveillance activities. The consortium also serves as a forum for stakeholders to share information on project results and initiatives as well as to develop common tools and protocols for use in individual surveillance zones. In addition to the nine Africhol countries, members include national and international organizations involved in the control or assessment of cholera in Africa:

The project directorate based at the Agence de Médecine Préventive (AMP), in coordination with the consortium members and the scientific advisory board makes all decisions on project organization, coordination, and technical specifications of the tools and procedures used for surveillance.

The external advisory board provides support in the diagnosis and surveillance of cholera. It is independent of the consortium and the pharmaceutical industry. Members are experts in the field of cholera and disease surveillance:

  • G. Balakrish Nair, MsC, PhD, National Institute of Cholera and Enteric Diseases, Kolkata, India
  • John Clemens, MD, International Vaccine Institute, Seoul, South Korea
  • Karen Keddy, PhD, National Institute for Communicable Diseases, Johannesburg, South Africa
  • Myron Levine, MD, DTPH, Center for Vaccine Development, University of Maryland, USA
  • Marie-Laure Quilicci, MD, French National Reference Center for Vibrios and Cholera, Pasteur Institute, France
  • Professor Papa Salif Sow, Centre Hospitalier Universitaire de Fann, Dakar, Senegal
  • David Sack, MD, Johns Hopkins University, USA